Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Roche Diagnostics Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (185)
Cancellation by sponsor (46)
COVID-19 test kit (5)

Date

2024 (26)
2023 (24)
2022 (16)
2021 (8)
2020 (21)
2019 (11)
2018 (39)
2017 (19)
2016 (6)
2015 (5)
2014 (7)
2013 (11)
2012 (15)
2011 (10)
2010 (18)

Results for "[search-keyword]"

Search

Sponsor content

236 result(s) found, displaying 161 to 170

Roche Diagnostics Australia Pty Limited - Anti-HBc - Hepatitis B virus core total antibody IVD, kit, chemiluminescent immunoassay Cancelled under Section 41GL(d) of the Act

31 May 2018

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Specimen receptacle IVDs Cancelled under Section 41GL(d) of the Act

30 May 2018

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Specimen receptacle IVDs Cancelled under Section 41GL(d) of the Act

30 May 2018

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Instrument/analyser IVDs Cancelled under Section 41GL(d) of the Act

30 May 2018

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Clinical chemistry substrate IVDs Cancelled under Section 41GL(d) of the Act

30 May 2018

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Immunohistology cell marker IVDs (248292)

15 July 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Roche Diagnostics Australia Pty Limited - Immunohistology cell marker IVDs.
Roche Diagnostics Australia Pty Limited - Instrument/analyser IVDs (238854)

25 May 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Roche Diagnostics Australia Pty Limited - Instrument/analyser IVDs.
Roche Diagnostics Australia Pty Limited - Cobas Ampliscreen HCV Test (Version 2) - Hepatitis C virus nucleic acid IVD, kit, nucleic acid technique (NAT) Cancelled under s41GL(d) of the Act

6 February 2018

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Cobas Ampliscreen HIV-1 (Version 1.5) - HIV1 nucleic acid IVD, kit, nucleic acid technique (NAT) Cancelled under s41GL(d) of the Act

6 February 2018

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Cobas Ampliscreen HBV test - Hepatitis B virus core nucleic acid IVD, kit, nucleic acid technique (NAT) Cancelled under s41GL(d) of the Act

6 February 2018

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited

Pages

First page
Previous page
…
Page 13
Page 14
Page 15
Page 16
Current page 17
Page 18
Page 19
Page 20
Page 21
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.